12:00 AM
 | 
Aug 12, 2013
 |  BC Week In Review  |  Company News  |  Deals

Cell Signaling Technology, Cepheid deal

Cell Signaling granted Cepheid a non-exclusive, worldwide license to Cell Signaling's patents covering the detection of anaplastic lymphoma kinase (ALK) gene rearrangements...

Read the full 99 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >